In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Alex Guillen, global pharma and life sciences director at Tive, outlines the technological obstacles that lie ...

In the final part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Ed Schoonveld value & access advisor for Schoonveld Advisory and author of The Price of Global Health, previews ...

Upperton Pharma Solutions, a contract development and manufacturing organization (CDMO), has completed the construction of its new 7,000 square-foot sterile manufacturing facility in Nottingham, UK, 1 ...

In the first part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Amanda Salindong, associate director of channel & distribution at Alnylam Pharmaceuticals, explains the premise ...

Known as AVT05, the Alvotech medication is a proposed biosimilar to Simponi, prescribed to treat various inflammatory conditions. The FDA is set to review the Biologics License Applications (BLAs) for ...

In a video interview with Pharma Commerce, Amanda Salindong, associate director of channel & distribution at Alnylam Pharmaceuticals, explains how she participated in two key sessions: “Trade 101” and ...

Besides the traditional obesity treatments of a healthy diet and exercise, the pharmaceutical industry has played a role in these efforts with the introduction of glucagon-like-peptide-1 (GLP-1) ...

In the second part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Amanda Salindong, associate director of channel & distribution at Alnylam Pharmaceuticals, describes how she ...

A cross-sectional study investigates the impact of Dobbs v Jackson’s Women’s Health Organization on national support and personal interest. In June 2022, the US Supreme Court overturned the ...

The investment not only moves along the company’s efforts in advancing clinical studies, but also opens up 700 new jobs for the Greater Toronto area. AstraZeneca will be investing $570 million in ...

Despite challenges surrounding communication overload, drug shortages, and cybersecurity risks, this term is revolutionizing medication management and patient care through the use artificial ...

In the final part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Jon Kostas, executive director, Association for Prescription Psychedelics (APP), describes the randomized ...